Optimism amid grim forecast: Dr. Isaac Y. Kim disputes projections of rising prostate cancer deaths, predicting declines through better diagnostics and treatments. Screening evolution: PSA testing, ...
As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about navigating treatment option in prostate cancer. Advancements in prostate ...
Extracellular vesicles shed by prostate cancer cells to the bloodstream contain tumor-derived material that can be used as biomarkers of therapy response and resistance in patients with metastatic ...
If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...
A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...
Therapy-resistant subclones as drivers of progression in aggressive variant prostate cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary Cancers Symposium. This abstract does not ...
Black men have a higher risk of prostate cancer. Surgery is sometimes the best treatment option for certain tumors. MSK ...
Most men with low-grade prostate cancer have an excellent prognosis, with a five-year survival rate of more than 99%. But ...
orgovyx (relugolix) is a medicine used to treat advanced prostate cancer in adults. Advanced prostate cancer means that the cancer has spread outside of the prostate. Advanced cancers have often come ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results